Second keynote of Single-Use Event 2023 will be about antibody-drug-conjugates
The second keynote of Single-Use Event 2023 will come from the company Byondis. It will be about antibody-drug-conjugates (ADC's). The speaker is to be announced soon.
Byondis is a clinical stage biopharmaceutical research and development company, with the mission to create safe and effective precision medicines targeting intractable cancers and autoimmune diseases, improving the standard of care for patients.
At Single-Use Event 2023 a spokesperson from the company will give a keynote centered around ADCs. More information about the contents of the keynote will follow soon.
Single Use Event 2023Registration website for Single Use Event 2023
Single Use Event 2023Single Use Event 20230.00EUROnlineOnly2019-01-01T00:00:00Z
CORPUSCORPUSWillem Einthovenstraat 1 2342BH Oegstgeest Netherlands